Ovarian Cancer
Introductory Remarks & Presentation of the SOLO1 trial (webcasts below):
-
Introductory Remarks - Susana Banerjee, London
NEJM: Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
K. Moore and Others
DOI: 10.1056/NEJMoa1810858 | October 21, 2018